Covariate | p-Value | HR | 95%CI |
---|---|---|---|
Total Dose | 0.01 | 0.08 | 0.01–0.63 |
Localization of tumour | 0.04 | 0.26 | 0.06–1.10 |
PV thrombosis | <0.001 | 3.51 | 2.01–6.13 |
AJCC Stage | 0.001 | 1.42 | 1.10–3.01 |
BCLC Stage | <0.001 | 1.38 | 0.95–2.84 |
Child Class | 0.04 | 1.63 | 1.02–2.61 |
AFP initial level | <0.001 | 0.39 | 0.25–0.63 |
Tumour volume | <0.001 | 0.25 | 0.16–0.40 |
Age | 0.006 | 2.02 | 1.20–3.39 |
Entropy (Histogram) | 0.02 | 1.70 | 1.09–2.67 |
Compacity | <0.001 | 0.22 | 0.14–0.36 |
Contrast | 0.01 | 2.11 | 1.14–4.12 |
Entropy | 0.04 | 1.61 | 1.03–2.88 |
Dissimilarity | 0.01 | 2.17 | 1.14–4.12 |
HGRE | 0.02 | 1.80 | 1.07–3.01 |
SRHGE | 0.02 | 1.69 | 1.06–2.67 |
LRHGE | 0.04 | 1.71 | 1.02–2.88 |
GLNU | <0.001 | 0.23 | 0.13–0.39 |
RLNU | <0.001 | 0.25 | 0.16–0.40 |
HGZE | 0.02 | 1.83 | 1.09–3.07 |
SZHGE | 0.01 | 1.80 | 1.12–2.87 |
GLNU | <0.001 | 0.25 | 0.15–0.39 |